Preoperative Plasma Insulin-Like Growth Factor-I and Its Binding Proteins-Based Risk Stratification of Patients Treated With Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

Mehdi Kardoust Parizi, Morgan Rouprêt, Nirmish Singla, Jeremy Yuen‐Chun Teoh, Piotr Chlosta, Marek Babjuk, Mohammad Abufaraj, Vitaly Margulis, David D‘Andrea, Jakob Klemm, Akihiro Matsukawa, Ekaterina Laukhtina, Tamas Fazekas, Pierre I Karakiewicz, Raj Bhanvadia, Paolo Gontero, Shahrokh F ShariatClinical 2024 · DOI

Abstract

We confirmed that a lower plasma levels of IGFBP-2 and -3 both are independent and clinically significant predictors of adverse pathological features and survival outcomes in UTUC patients treated with RNU. These findings might help guide the clinical decision-making regarding perioperative systemic therapy and follow-up scheduling.
BibTeX
@inproceedings{parizi2024preoperative,
  author = {Mehdi Kardoust Parizi and Morgan Rouprêt and Nirmish Singla and Jeremy Yuen‐Chun Teoh and Piotr Chlosta and Marek Babjuk and Mohammad Abufaraj and Vitaly Margulis and David D‘Andrea and Jakob Klemm and Akihiro Matsukawa and Ekaterina Laukhtina and Tamas Fazekas and Pierre I Karakiewicz and Raj Bhanvadia and Paolo Gontero and Shahrokh F Shariat},
  title = {{Preoperative Plasma Insulin-Like Growth Factor-I and Its Binding Proteins-Based Risk Stratification of Patients Treated With Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma}},
  booktitle = {Clinical},
  year = {2024},
  doi = {10.1016/j.clgc.2024.102133},
}

Loading related content...

Figure